ProRelix Research – Immediate Hiring for CRA, CTA & CDM Roles | Apply Now


ProRelix Research – Immediate Openings for CRAs, CTAs & CDM Roles

  • 📅 Published on: July 18, 2025
  • 📌 Positions: Clinical Research Associates, Trial Assistants & Data Managers
  • 🏢 Company: ProRelix Research
  • 🎓 Qualification: B.Pharm, M.Pharm, Pharm.D, MSc, BSc, Lifesciences, Medicine
  • 📍 Location: Pune, Maharashtra
  • 💼 Experience: 0 - 8 Years+
  • 📝 Mode of Application: Email 


🔎 About the Company

ProRelix Research is a globally recognized Contract Research Organization (CRO) dedicated to advancing clinical trials and drug development. We deliver patient-centric, high-quality research solutions and support some of the world’s leading pharma & biotech companies.


🧪 Detailed Job Openings

1. Clinical Research Associate – I (CRA-I)

  • Experience: 1+ years
  • Responsibilities:
    • Conduct PSV, SIV, RMV, and COV visits
    • Ensure protocol & regulatory compliance
    • Review CRFs & source docs

2. Clinical Research Associate – II (CRA-II)

  • Experience: 2–3 years
  • Responsibilities:
    • Lead site management & training
    • Risk-based monitoring
    • Liaison with sponsors

3. Clinical Trial Assistant – I (CTA-I)

  • Experience: 0–6 months (Freshers Welcome)
  • Responsibilities:
    • TMF maintenance, documentation
    • Track site communications

4. Clinical Data Management – Manager

  • Experience: 8+ years
  • Responsibilities:
    • Oversee data cleaning & validation
    • Lead database lock & EDC tools
    • Ensure CDISC, 21 CFR Part 11 compliance

✅ Eligibility & Skills

  • Degree in Life Sciences, Pharmacy, or Medicine
  • Good understanding of ICH-GCP, FDA/EMA
  • CRAs must be willing to travel (50–70%)
  • CDM must have tools like SAS, Rave, Oracle Clinical

🎯 Why Join ProRelix?

  • Attractive salary + performance bonuses
  • Hybrid/Remote options for eligible roles
  • Career development & global exposure

📩 How to Apply?

⏳ Please wait 15 seconds to reveal the application email...

Post a Comment

0 Comments